ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » New Jersey » Geriatric Medicine

Top Geriatric Medicine Prescribers in New Jersey

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
JOEL ROSS MD

Geriatric Medicine

497

$84.5K

65
57 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

49%
prescriptions for brand name drugs

Avg: 29%

$170
Average prescription price

Avg: $67

JEN-LIH KOU M.D.

Geriatric Medicine

832

$33.6K

84
16 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 29%

$40
Average prescription price

Avg: $67

MUKTA BANSAL M.D.

Geriatric Medicine

838

$37.6K

174
166 are 65+

31%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 29%

$45
Average prescription price

Avg: $67

SAMEER PATEL MD

Geriatric Medicine

1,070

$60.2K

162
129 are 65+

14%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 29%

$56
Average prescription price

Avg: $67

QIAN WANG MD

Geriatric Medicine

1,490

$108K

234
212 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 29%

$73
Average prescription price

Avg: $67

LILIANE QUINLAN MD

Geriatric Medicine

1,594

$109K

213
179 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 29%

$68
Average prescription price

Avg: $67

FLORENCE EATMAN M.D.

Geriatric Medicine

1,606

$110K

78
73 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 3%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 29%

$69
Average prescription price

Avg: $67

SRILALITHA DONEPUDI M.D.

Geriatric Medicine

1,649

$96.9K

149
62 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

11%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 29%

$59
Average prescription price

Avg: $67

KANNAN SIVARAJU

Geriatric Medicine

1,682

$84K

201
187 are 65+

8%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 29%

$50
Average prescription price

Avg: $67

IRA STEIN MD

Geriatric Medicine

1,717

$127K

164
153 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 29%

$74
Average prescription price

Avg: $67

INDERPREET SACHAR M.D.

Geriatric Medicine

1,861

$97.2K

205
198 are 65+

8%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 29%

$52
Average prescription price

Avg: $67

ANTHONY NATELLI MD

Geriatric Medicine

1,866

$162K

136
129 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 29%

$87
Average prescription price

Avg: $67

SHIRA GOLDBERG MD

Geriatric Medicine

1,870

$151K

253
237 are 65+

5%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 29%

$81
Average prescription price

Avg: $67

RANDY ROWLANDS M.D.

Geriatric Medicine

1,878

$170K

272
202 are 65+

4%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

37%
prescriptions for brand name drugs

Avg: 29%

$90
Average prescription price

Avg: $67

KATHRYN PEPER M.D

Geriatric Medicine

1,881

$96.1K

64
62 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 29%

$51
Average prescription price

Avg: $67

ERINN BEAGIN M.D.

Geriatric Medicine

1,909

$170K

161
150 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 29%

$89
Average prescription price

Avg: $67

CHERYL ZIEMBA MD

Geriatric Medicine

1,958

$92.8K

208
207 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 29%

$47
Average prescription price

Avg: $67

HARPREET SIDHU MD

Geriatric Medicine

2,103

$130K

122
110 are 65+

32%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 29%

$62
Average prescription price

Avg: $67

ALEXANDER KOLESSA M.D.

Geriatric Medicine

2,191

$94K

184
167 are 65+

18%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 29%

$43
Average prescription price

Avg: $67

ROLAND LOSOS MD

Geriatric Medicine

2,255

$203K

201
178 are 65+

7%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 29%

$90
Average prescription price

Avg: $67

WILLIAM BOYAN M.D.

Geriatric Medicine

2,275

$187K

225
215 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

9%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 29%

$82
Average prescription price

Avg: $67

URMI DAS M.D.

Geriatric Medicine

2,423

$170K

172
143 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 29%

$70
Average prescription price

Avg: $67

PRANAB HALDAR MD

Geriatric Medicine

2,439

$165K

66
57 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 29%

$67
Average prescription price

Avg: $67

SUDHA KOLLI MD

Geriatric Medicine

2,464

$159K

160
130 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 29%

$64
Average prescription price

Avg: $67

KEERTI SHARMA M.D.

Geriatric Medicine

2,540

$150K

195
187 are 65+

10%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 29%

$59
Average prescription price

Avg: $67

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank